CFH and Polypoidal choroidal vasculopathy: Among CNV and/or polypoidal choroidal vasculopathy patients, usually considered a subtype of CNV, also there are SNPs associated with variable response to ranibizumab, bevacizumab or PDT as HTRA1-625 A/G (rs11200638), F13A1 (rs5985) CFH I62V (rs800292), CFH Y402H (rs1061170) and, especially, ARMS2 A69S (rs10490924) [33].